Guy P. Nohra - 11 Feb 2021 Form 3/A - Amendment Insider Report for Bioventus Inc. (BVS)

Role: Director
Signature: /s/ Anthony D'Adamio, Attorney-in-Fact
Issuer symbol: BVS
Transactions as of: 11 Feb 2021
Net transactions value: $0
Form type: 3/A - Amendment
Filing time: 23 Aug 2023, 17:38:39 UTC
Date Of Original Report: 11 Feb 2021
Next filing: 15 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BVS	Class A Common Stock						2,604,264	11 Feb 2021	See Footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported shares are held by Alta Partners VIII, L.P. ("Alta VIII"). Alta Partners Management VIII, LLC ("Alta Management") is the general partner of Alta VIII. The Reporting Person is one of the managing directors and a member of Alta Management and shares voting and dispositive power with respect to the shares held by Alta VIII. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his proportionate pecuniary interest therein.

Content

The reported shares are held by Alta Partners VIII, L.P. ("Alta VIII"). Alta Partners Management VIII, LLC ("Alta Management") is the general partner of Alta VIII. The Reporting Person is one of the managing directors and a member of Alta Management and shares voting and dispositive power with respect to the shares held by Alta VIII. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of his proportionate pecuniary interest therein.